4-1BB Costimulatory Signals Preferentially Induce CD8+ T Cell Proliferation and Lead to the Amplification In Vivo of Cytotoxic T Cell Responses
Walter W. Shuford(Emory University), Robert S. Mittler(Ortho Clinical Diagnostics (United States)), Kerry Klussman(Seagen (United States)), Douglas D. Tritchler(Emory University), Thomas C. Pearson(Emory Healthcare), Hong Raecho(Emory University), Anthony W. Siadak(Seagen (United States)), John Emswiler(Bristol-Myers Squibb (United States)), Christian P. Larsen(Emory University Hospital), Deryk Loo(Ecogenomics (Japan)), Alejandro Aruffo(University of Washington Medical Center), Jeffrey A. Ledbetter(University of Washington), T J Brown(Emory University), Jan Chalupny(Emory University)
Cited by 802
Related Papers
Long-term acceptance of skin and cardiac allografts after blocking CD40 and CD28 pathways
|Nature|1996|1.5k
cAC10-vcMMAE, an anti-CD30–monomethyl auristatin E conjugate with potent and selective antitumor activity
|Blood|2003|918
The CD40 ligand, gp39, is defective in activated T cells from patients with X-linked hyper-IgM syndrome
|Cell|1993|824
Rational Development of LEA29Y (belatacept), a High-Affinity Variant of CTLA4-Ig with Potent Immunosuppressive Properties
|American Journal of Transplantation|2005|714
IMMUNE REGULATION BY CD40 AND ITS LIGAND GP39
|Annual Review of Immunology|1996|640